19 February 2021>: Original Paper
Short- and Long-Term Outcomes of Different Reperfusion Sequences in Liver Transplantation
Ann-Kathrin Eichelmann 1BCEF** , Thomas Vogel 1ABE* , Ann-Kathrin Fuchs 1BC , Philipp Houben 1DE , Shadi Katou 1BDF , Felix Becker 1CD , Hartmut H. Schmidt 2AD , Christian Wilms 2DF , Andreas Pascher 1BD , Jens G. Brockmann 1ACDEDOI: 10.12659/AOT.926847
Ann Transplant 2021; 26:e926847
Table 1 Recipient data.
PV | A | SIM | p | |
---|---|---|---|---|
Age (y) | 49 (24–66) | 55 (31–66) | 59 (46–69) | 0.01 |
Gender; Male: Female | 18: 7 | 12: 10 | 7: 7 | 0.3 |
MELD | 17 (6–40) | 19 (6–40) | 22 (7–40) | 0.3 |
Diagnosis | ||||
Acute liver failure | 3 | 2 | 5 | 0.4 |
Cirrhosis | 10 | 10 | 3 | |
HCC | 8 | 8 | 4 | |
Amyloidosis | 2 | 1 | 0 | |
Polycystic liver disease | 2 | 1 | 2 | |
PV – primary portal venous reperfusion; A – primary arterial reperfusion; SIM – simultaneous reperfusion; Y – years; MELD – model for end-stage liver disease; HCC – hepatocellular carcinoma. |